Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Neoplasms 1 Multiple Myeloma 1 Lymphoma, Non-Hodgkin 1 Colorectal Neoplasms 1 Breast Neoplasms 1

Interventions

Bevacizumab 25 Fluorouracil 23 Leucovorin 22 Cetuximab 22 Oxaliplatin 19 pembrolizumab 14 Specimen Handling 11 Irinotecan 10 Nivolumab 8 Magnetic Resonance Spectroscopy 8 Biopsy 7 atezolizumab 6 fludarabine 5 encorafenib 5 Pemetrexed 5 Panitumumab 5 HMPL-013 5 Gemcitabine 5 Folfox protocol 5 Cisplatin 5 Carboplatin 5 trifluridine tipiracil drug combination 4 balstilimab 4 Standard of Care 4 Immunoglobulin G 4 Disulfides 4 Cyclophosphamide 4 regorafenib 3 fludarabine phosphate 3 dehydroftorafur 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Colorectal Neoplasms × tucatinib × 30 days × Clear all

NCT05253651 2026-06-04

MOUNTAINEER-03

Seagen Inc.

Phase 3 Recruiting

Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡